Several molecules have been proposed as biomarkers for injury severity, response to treatment, and predictors of outcomes after head trauma, including glial acidic fibrillary protein (GFAP) [43], neuron-specific enolase (NSE), and S100B [44]. The gene discussed is ENO2; the disease is injury.